BP
MRNA icon

BNP Paribas’s Moderna MRNA Stock Holding History

BNP Paribas’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Hold
2,950
– – 0.01% 212
2026
Q1 		$150K Sell
2,950
-850
-22% -$39.7K ﹤0.01% 232
2025
Q4 		$112K Hold
3,800
– – ﹤0.01% 257
2025
Q3 		$98.2K Hold
3,800
– – ﹤0.01% 241
2025
Q2 		$105K Hold
3,800
– – ﹤0.01% 246
2025
Q1 		$108K Buy
3,800
+3,200
+533% +$114K ﹤0.01% 244
2024
Q4 		$24.9K Buy
600
+215
+56% +$10.3K ﹤0.01% 306
2024
Q3 		$25.7K Sell
385
-532
-58% -$48.8K ﹤0.01% 291
2024
Q2 		$110K Sell
917
-100
-10% -$12.7K 0.01% 235
2024
Q1 		$109K Buy
+1,017
New +$103K 0.01% 244

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

BNP Paribas's MRNA Position: Q2 2026 in Review

BNP Paribas held its Moderna (MRNA) position steady in Q2 2026 at 2,950 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #212.

BNP Paribas first reported a position in MRNA in Q1 2024 and has held it in 10 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • BNP Paribas held 2,950 shares of Moderna worth $207K as of Q2 2026.
  • BNP Paribas left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.01% of BNP Paribas's portfolio in Q2 2026, its #212 holding.
  • BNP Paribas first reported a position in Moderna in Q1 2024 and has held it in 10 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.